These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments. Benharouga M; Haardt M; Kartner N; Lukacs GL J Cell Biol; 2001 May; 153(5):957-70. PubMed ID: 11381082 [TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of a yeast plasma membrane receptor signals its ligand-stimulated endocytosis. Hicke L; Riezman H Cell; 1996 Jan; 84(2):277-87. PubMed ID: 8565073 [TBL] [Abstract][Full Text] [Related]
6. Cystic fibrosis problem probed by proteolysis. Welsh MJ; Ostedgaard LS Nat Struct Biol; 1998 Mar; 5(3):167-9. PubMed ID: 9501902 [No Abstract] [Full Text] [Related]
7. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. Mitch WE; Goldberg AL N Engl J Med; 1996 Dec; 335(25):1897-905. PubMed ID: 8948566 [No Abstract] [Full Text] [Related]
8. A principal role for the proteasome in endoplasmic reticulum-associated degradation of misfolded intracellular cystic fibrosis transmembrane conductance regulator. Gelman MS; Kannegaard ES; Kopito RR J Biol Chem; 2002 Apr; 277(14):11709-14. PubMed ID: 11812794 [TBL] [Abstract][Full Text] [Related]
9. Molecular biology. New proteases in a ubiquitin stew. Hochstrasser M Science; 2002 Oct; 298(5593):549-52. PubMed ID: 12386321 [No Abstract] [Full Text] [Related]
10. Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism. Gelman MS; Kopito RR Methods Mol Biol; 2003; 232():27-37. PubMed ID: 12840537 [No Abstract] [Full Text] [Related]
11. A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Hofmann K; Falquet L Trends Biochem Sci; 2001 Jun; 26(6):347-50. PubMed ID: 11406394 [TBL] [Abstract][Full Text] [Related]
13. [Ligand-induced polyubiquitination of receptor tyrosine kinases]. Mori S Tanpakushitsu Kakusan Koso; 1997 Oct; 42(14 Suppl):2284-90. PubMed ID: 9366209 [No Abstract] [Full Text] [Related]
14. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Jensen TJ; Loo MA; Pind S; Williams DB; Goldberg AL; Riordan JR Cell; 1995 Oct; 83(1):129-35. PubMed ID: 7553864 [TBL] [Abstract][Full Text] [Related]
15. The ubiquitin-proteasome proteolytic pathway. Ciechanover A Cell; 1994 Oct; 79(1):13-21. PubMed ID: 7923371 [No Abstract] [Full Text] [Related]
16. Impairment of the ubiquitin-proteasome system by protein aggregation. Bence NF; Sampat RM; Kopito RR Science; 2001 May; 292(5521):1552-5. PubMed ID: 11375494 [TBL] [Abstract][Full Text] [Related]
17. In vitro reconstitution of CFTR biogenesis and degradation. Oberdorf J; Skach WR Methods Mol Med; 2002; 70():295-310. PubMed ID: 11917531 [No Abstract] [Full Text] [Related]
18. Abnormal lysosomal and ubiquitin-proteasome pathways in 19p13.3 distal myopathy. Di Blasi C; Moghadaszadeh B; Ciano C; Negri T; Giavazzi A; Cornelio F; Morandi L; Mora M Ann Neurol; 2004 Jul; 56(1):133-8. PubMed ID: 15236412 [TBL] [Abstract][Full Text] [Related]
19. Redundancy of mammalian proteasome beta subunit function during endoplasmic reticulum associated degradation. Oberdorf J; Carlson EJ; Skach WR Biochemistry; 2001 Nov; 40(44):13397-405. PubMed ID: 11683650 [TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-proteasome pathway regulates lysosomal degradation of the growth hormone receptor and its ligand. van Kerkhof P; Strous GJ Biochem Soc Trans; 2001 Aug; 29(Pt 4):488-93. PubMed ID: 11498015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]